TY - JOUR
KW - Adolescent
KW - Adult
KW - Analgesics, Opioid/therapeutic use
KW - buprenorphine
KW - Buprenorphine, Naloxone Drug Combination
KW - Buprenorphine/therapeutic use
KW - Female
KW - Humans
KW - Male
KW - Medication Adherence/statistics & numerical data
KW - Methadone
KW - Methadone/therapeutic use
KW - Middle Aged
KW - Naloxone/therapeutic use
KW - Narcotic Antagonists/therapeutic use
KW - opiate dependence
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/rehabilitation
KW - Treatment Outcome
KW - Treatment Outcomes
KW - Young Adult
AU - Y. I. Hser
AU - A. J. Saxon
AU - D. Huang
AU - A. Hasson
AU - C. Thomas
AU - M. Hillhouse
AU - P. Jacobs
AU - C. Teruya
AU - P. McLaughlin
AU - K. Wiest
AU - A. Cohen
AU - W. Ling
A1 - 
BT - Addiction (Abingdon, England)
C5 - Opioids & Substance Use
CP - 1
CY - England
DO - 10.1111/add.12333
IS - 1
JF - Addiction (Abingdon, England)
PB - Society for the Study of Addiction
PP - England
PY - 2014
SN - 1360-0443; 0965-2140
SP - 79
EP - 87
EP - 
T1 - Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
T2 - Addiction (Abingdon, England)
TI - Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
U1 - Opioids & Substance Use
U2 - 23961726
U3 - 10.1111/add.12333
VL - 109
VO - 1360-0443; 0965-2140
Y1 - 2014
ER -